#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ischaemic stroke Congenital megacolon Osteogenesis imperfecta T-cell type acute leukaemia Biotinidase deficiency Castleman's disease Astrocytoma Isodicentric chromosome 15 syndrome Arterial disorder Narcolepsy Haemolytic uraemic syndrome Blastic plasmacytoid dendritic cell neoplasia Still's disease Mucopolysaccharidosis II Non-Hodgkin's lymphoma unspecified histology indolent More trials…

    Learn about Rare Diseases

    Progressive multifocal leukoencephalopathy – Treatment Netherton’s syndrome – Trials in Disease Mucopolysaccharidosis I Atypical haemolytic uraemic syndrome Congenital generalised lipodystrophy – Life with Disease Crigler-Najjar syndrome – Trials in Disease Kearns-Sayre syndrome – Treatment Lymphatic malformation – Trials in Disease Immunodeficiency congenital – Life with Disease Uterine leiomyosarcoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lt3001 Auto4 Dexamethasone Acetate Rintatolimod Pevonedistat Tetracosactide Neflamapimod R2R01 Dordaviprone Capmatinib Roxadustat Rozanolixizumab Lerodalcibep Psma-11 Neob Xtmab-16 ACT-1004-1239 Sodium Picosulfate Enoxaparin Sodium CHONDROITIN SULFATE SODIUM More therapies…

    Learn about Your Condition

    Hereditary optic atrophy Brain neoplasm Bone sarcoma Nasal sinus cancer Meniscus injury Indolent systemic mastocytosis Renal cancer metastatic Paget's disease of the vulva Primary biliary cholangitis Lip and/or oral cavity cancer Ewing's sarcoma metastatic Acquired haemophilia Breast conserving surgery Ectopic pregnancy Drug use disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hypersomnia

  • Long-term Safety Study of ORX750 for Patients with Narcolepsy and Idiopathic Hypersomnia Who Completed a Previous ORX750 Trial

    Recruiting

    4 1 1
    Investigated Diseases:
    • Hypersomnia
    • Narcolepsy
    Investigated Drugs:
    • ORX750
    France Italy Spain

  • Study of ALKS 2680 to treat excessive daytime sleepiness in people with idiopathic hypersomnia

    Recruiting

    2 1
    Investigated Diseases:
    • Hypersomnia
    Investigated Drugs:
    • Alks 2680
    Belgium Czechia France Italy The Netherlands Spain

  • Study on the Safety and Effects of ORX750 for Patients with Narcolepsy and Idiopathic Hypersomnia

    Recruiting

    2 1
    Investigated Drugs:
    • ORX750
    France Italy Spain

  • Study of TAK-360 tablets to evaluate safety and effectiveness in people with Idiopathic Hypersomnia

    Recruiting

    2 1
    France Italy Spain

  • Long-Term Study on the Safety and Effects of ALKS 2680 for Patients with Narcolepsy Type 1 and Type 2

    Recruiting

    4 1 1
    Investigated Diseases:
    • Hypersomnia
    • Narcolepsy
    Investigated Drugs:
    • Alks 2680
    Belgium Czechia France Italy The Netherlands Spain

  • Study on Melatonin and Light Therapy for Adults with Idiopathic Hypersomnia

    Recruiting

    2 1
    Investigated Diseases:
    • Hypersomnia
    Investigated Drugs:
    • Melatonin
    France

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!